No profile data available.
Bioqual, Inc. (BIOQ) is a healthcare company in the early-stage drug development research industry, based in Rockville, United States.
It reported revenue of $35.88 million for fiscal year 2018, down 2.0% from fiscal year 2017, and net income of $3.66 million. In Q2 2026 (the quarter ended November 30, 2025) revenue was $10.98 million, down 3.7% from a year before. Its market capitalization was $29.52 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended May 31, 2018; market data as of October 9, 2026.
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.
Bioqual reported $35.88 million in revenue for fiscal year 2018, down 2.0% from $36.60 million in fiscal year 2017. In Q2 2026 revenue was $10.98 million.
$29.52 million as of October 9, 2026.
Listed companies of a similar size in the same industry (early-stage drug development research) include Charles River Laboratories International, Inc. (CRL), Champions Oncology, Inc. (CSBR).